Physician

Alexander David Tapper, M.D.

According to 2025 Medicare claims, Alexander Tapper, M.D. (NPI: 1205215621) practices urology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Oakland, MI. This provider's primary affiliated billing organization is MICHIGAN INSTITUTE OF UROLOGY PC (NPI: 1427027416; TIN: 381962231) and primary practice location at 48346-5405. Tapper is affiliated with the Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Tapper's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,080 traditional Medicare patients, billed 13,078 HCPCS/CPT codes, and received $410,021 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,282 prescription claims across 850 beneficiaries totaling $2,198,887 in drug costs, led by Xtandi (Enzalutamide). DME data shows 40 claims. Open Payments data shows 66 records totaling $1,802. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $136,935 to $410,021. Similarly, Part D prescription costs have moved sharply higher in recent years, from $274 to $2,198,887. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	390	4,177	$136,935
2021	712	7,566	$292,857
2022	837	8,459	$305,408
2023	874	8,716	$448,173
2024	1,080	13,078	$410,021

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	28	37	$274
2016	111	140	$1,218
2017	120	181	$3,178
2018	61	90	$3,141
2019	41	59	$3,085
2020	204	413	$22,086
2021	400	1,232	$79,211
2022	526	1,704	$277,966
2023	632	2,373	$667,052
2024	850	3,282	$2,198,887

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	55	$22,978
2022	N/R	19	$3,931
2023	N/R	28	$4,573
2024	N/R	40	$31,068

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	620	948	$96
84153	Psa (prostate specific antigen) measurement, total	200	249	$18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	582	838	$13
51798	Ultrasound measurement of bladder capacity after voiding	356	463	$9
81003	Automated urinalysis test	725	1,265	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	87	2,610	$1,221,725
Erleada	Apalutamide	18	540	$253,700
Myrbetriq	Mirabegron	188	10,355	$150,220
Gemtesa	Vibegron	133	7,396	$116,182
Orgovyx	Relugolix	43	1,284	$111,251

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	20	$26,037
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	20	$5,031

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	66	$1,802	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alexander David Tapper, M.D.?

Tedicare shows public-source Medicare data for Alexander David Tapper, M.D. (NPI 1205215621), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander David Tapper, M.D. have ACO affiliation data?

Alexander David Tapper, M.D. is shown with ACO affiliation data for Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Alexander David Tapper, M.D.?

Alexander David Tapper, M.D. is linked to MICHIGAN INSTITUTE OF UROLOGY PC (billing NPI 1427027416) in the available physician profile data.

Does Alexander David Tapper, M.D. have Open Payments data?

Alexander David Tapper, M.D. has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.